<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>PURPOSE: Persistent smoking among <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> survivors may increase their risk of subsequent <z:e sem="disease" ids="C0006826" disease_type="Neoplastic Process" abbrv="">malignancies</z:e>, including tobacco-related <z:e sem="disease" ids="C0006826" disease_type="Neoplastic Process" abbrv="">malignancies</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>Despite these risks, nearly 40 % of women diagnosed with <z:e sem="disease" ids="C0302592" disease_type="Neoplastic Process" abbrv="">cervical cancer</z:e> continue to smoke after diagnosis </plain></SENT>
<SENT sid="2" pm="."><plain>This study describes the relative risk of developing any subsequent and tobacco-related <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">malignancy</z:e> among <z:e sem="disease" ids="C0302592" disease_type="Neoplastic Process" abbrv="">cervical cancer</z:e> survivors </plain></SENT>
<SENT sid="3" pm="."><plain>METHODS: We examined data from the year 1992 to 2008 in 13 Surveillance, Epidemiology and End Results registries </plain></SENT>
<SENT sid="4" pm="."><plain>We calculated the standardized incidence ratio (SIR) and 95 % confidence limits (CLs) for <z:hpo ids='HP_0000001'>all</z:hpo> subsequent and tobacco-related <z:e sem="disease" ids="C0006826" disease_type="Neoplastic Process" abbrv="">malignancies</z:e> among <z:e sem="disease" ids="C0302592" disease_type="Neoplastic Process" abbrv="">cervical cancer</z:e> survivors </plain></SENT>
<SENT sid="5" pm="."><plain>Tobacco-related <z:e sem="disease" ids="C0006826" disease_type="Neoplastic Process" abbrv="">malignancies</z:e> were defined according to the 2004 Surgeon General's Report on the Health Consequences of Smoking </plain></SENT>
<SENT sid="6" pm="."><plain>For comparison with <z:e sem="disease" ids="C0302592" disease_type="Neoplastic Process" abbrv="">cervical cancer</z:e> survivors, SIRs for subsequent <z:e sem="disease" ids="C0006826" disease_type="Neoplastic Process" abbrv="">malignancies</z:e> were also calculated for female survivors of breast or <z:e sem="disease" ids="C1527249" disease_type="Neoplastic Process" abbrv="">colorectal cancers</z:e> </plain></SENT>
<SENT sid="7" pm="."><plain>RESULTS: The SIR of developing a subsequent tobacco-related <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">malignancy</z:e> was higher among <z:e sem="disease" ids="C0302592" disease_type="Neoplastic Process" abbrv="">cervical cancer</z:e> survivors (SIR = 2.2, 95 % CL = 2.0-2.4) </plain></SENT>
<SENT sid="8" pm="."><plain>Female breast (SIR = 1.1, 95 % CL = 1.0-1.1) and <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> survivors (1.1, 1.1-1.2) also had an elevated risk </plain></SENT>
<SENT sid="9" pm="."><plain>The increased risk of a subsequent tobacco-related <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">malignancy</z:e> among <z:e sem="disease" ids="C0302592" disease_type="Neoplastic Process" abbrv="">cervical cancer</z:e> survivors was greatest in the first 5 years after the initial diagnosis and decreased as time since diagnosis elapsed </plain></SENT>
<SENT sid="10" pm="."><plain>CONCLUSION: Women with <z:e sem="disease" ids="C0302592" disease_type="Neoplastic Process" abbrv="">cervical cancer</z:e> have a two-fold increased risk of subsequent tobacco-related <z:e sem="disease" ids="C0006826" disease_type="Neoplastic Process" abbrv="">malignancies</z:e>, compared with breast and <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> survivors </plain></SENT>
<SENT sid="11" pm="."><plain>In an effort to decrease their risk of subsequent tobacco-related <z:e sem="disease" ids="C0006826" disease_type="Neoplastic Process" abbrv="">malignancies</z:e>, <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> survivors should be targeted for tobacco prevention and cessation services </plain></SENT>
<SENT sid="12" pm="."><plain>Special attention should be given to <z:e sem="disease" ids="C0302592" disease_type="Neoplastic Process" abbrv="">cervical cancer</z:e> survivors whose risk is almost twice that of breast or <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> survivors </plain></SENT>
</text></document>